Despite health department funding, Michigan has no state law explicitly authorizing SSP—but does have local ordinances against syringe access.

The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.

Learn more about the critical tests for ensuring the proper performance of auto-injectors, which are used for a variety of ...

A severely anorexic young woman was prescribed blockbuster weight loss jab Wegovy by one of the UK's biggest online ...

A coalition of news organizations is suing Tennessee’s top prisons official and a warden, alleging that state execution ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.